Every year millions of the world’s poorest people die from curable or preventable infectious diseases or suffer unnecessary ill health because they do not have access to basic health care services, including essential medicines and vaccines. The reasons for this are complex and plentiful....but these problems cannot be an excuse for inaction, writes Andrew Witty, CEO of GlaxoSmithKline.
The threat is no longer low-cost manufacturing; it’s high-tech and ideas. And the proof? As of this year, China has overtaken Germany as the world’s biggest exporter. And it’s not limited to less expensive products.
I have always advocated for investment in engineering – to both improve society and stimulate economies. It’s true that as engineer myself I have a vested interest. But following the financial fallout this is no longer just a point of view. It’s a necessity, writes Sir James Dyson.
One major bank's recent announcement that it will boost base pay while reducing bonus opportunities for certain employees spawned headlines around the globe, and with good reason.
CNBC viewers share their memories of CNBC Chief Commentator Bill Seidman.
CNBC Anchor Bill Griffeth shares memories of Bill Seidman that reflect on the special character of the former FDIC chairman and CNBC chief commentator.
Under the new "bailout" — "rescue" — legislation, Treasury will be purchasing billions of dollars of mortgage-backed securities — mostly backed by subprime mortgages.
The Fed could surprise markets Wednesday because of the wide divergence in Wall St. views about its next move.
Tesla shares are down since the market's recent high and one investment pro thinks it's a great time to buy. Here's why.
Check out which companies are making headlines after the bell Tuesday: Adobe, Apogee Enterprises & more.
The Russell 2000 has been diverging from the broader market, and technicians say it could be about to flash a very bearish signal.